
Gufic Biosciences Limited has informed the Exchange regarding a press release dated Jun 16, 2023, titled "Press Release Gufic receives approval from NMPA, China for Prilocaine API ".
Filed with NSE ·

Gufic Biosciences Limited has informed the Exchange regarding a press release dated Jun 16, 2023, titled "Press Release Gufic receives approval from NMPA, China for Prilocaine API ".
6ix hasn’t read this filing yet.
Gufic Biosciences Limited on 6ix
Follow Gufic Biosciences into a list and get an email when it puts out news.
Follow Gufic Biosciences